Literature DB >> 26555377

Engineering growth factors for regenerative medicine applications.

Aaron C Mitchell1, Priscilla S Briquez2, Jeffrey A Hubbell3, Jennifer R Cochran4.   

Abstract

Growth factors are important morphogenetic proteins that instruct cell behavior and guide tissue repair and renewal. Although their therapeutic potential holds great promise in regenerative medicine applications, translation of growth factors into clinical treatments has been hindered by limitations including poor protein stability, low recombinant expression yield, and suboptimal efficacy. This review highlights current tools, technologies, and approaches to design integrated and effective growth factor-based therapies for regenerative medicine applications. The first section describes rational and combinatorial protein engineering approaches that have been utilized to improve growth factor stability, expression yield, biodistribution, and serum half-life, or alter their cell trafficking behavior or receptor binding affinity. The second section highlights elegant biomaterial-based systems, inspired by the natural extracellular matrix milieu, that have been developed for effective spatial and temporal delivery of growth factors to cell surface receptors. Although appearing distinct, these two approaches are highly complementary and involve principles of molecular design and engineering to be considered in parallel when developing optimal materials for clinical applications. STATEMENT OF SIGNIFICANCE: Growth factors are promising therapeutic proteins that have the ability to modulate morphogenetic behaviors, including cell survival, proliferation, migration and differentiation. However, the translation of growth factors into clinical therapies has been hindered by properties such as poor protein stability, low recombinant expression yield, and non-physiological delivery, which lead to suboptimal efficacy and adverse side effects. To address these needs, researchers are employing clever molecular and material engineering and design strategies to both improve the intrinsic properties of growth factors and effectively control their delivery into tissue. This review highlights examples of interdisciplinary tools and technologies used to augment the therapeutic potential of growth factors for clinical applications in regenerative medicine.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterials; Controlled release; Drug delivery systems; Extracellular matrix; Growth factors; High-throughput screening; Mutagenesis; Protein engineering; Protein library; Regenerative medicine

Mesh:

Substances:

Year:  2015        PMID: 26555377      PMCID: PMC6067679          DOI: 10.1016/j.actbio.2015.11.007

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  92 in total

1.  Superagonistic activation of ErbB-1 by EGF-related growth factors with enhanced association and dissociation rate constants.

Authors:  A E Lenferink; E J van Zoelen; M J van Vugt; S Grothe; W van Rotterdam; M L van De Poll; M D O'Connor-McCourt
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 2.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 3.  Fibroblast growth factors, their receptors and signaling.

Authors:  C J Powers; S W McLeskey; A Wellstein
Journal:  Endocr Relat Cancer       Date:  2000-09       Impact factor: 5.678

4.  Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.

Authors:  A Sahni; C W Francis
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

5.  Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching".

Authors:  Casim A Sarkar; Ky Lowenhaupt; Thomas Horan; Thomas C Boone; Bruce Tidor; Douglas A Lauffenburger
Journal:  Nat Biotechnol       Date:  2002-08-05       Impact factor: 54.908

6.  Growth factor engineering by degenerate homoduplex gene family recombination.

Authors:  Wayne M Coco; Lance P Encell; William E Levinson; Michael J Crist; A Katrina Loomis; Laura L Licato; Joseph J Arensdorf; Nicole Sica; Philip T Pienkos; Daniel J Monticello
Journal:  Nat Biotechnol       Date:  2002-11-11       Impact factor: 54.908

7.  Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.

Authors:  S E Sakiyama-Elbert; J A Hubbell
Journal:  J Control Release       Date:  2000-10-03       Impact factor: 9.776

8.  Structural specificity of heparin binding in the fibroblast growth factor family of proteins.

Authors:  Rahul Raman; Ganesh Venkataraman; Steffen Ernst; V Sasisekharan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

9.  Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency.

Authors:  E V Shusta; M C Kieke; E Parke; D M Kranz; K D Wittrup
Journal:  J Mol Biol       Date:  1999-10-08       Impact factor: 5.469

Review 10.  Extracellular matrix and cytokines: a functional unit.

Authors:  E Schönherr; H J Hausser
Journal:  Dev Immunol       Date:  2000
View more
  60 in total

1.  The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Richard D Starke; Claire R Peghaire; Koval E Smith; Thomas A J McKinnon; Yoji Tabata; Koichi Sasaki; Michael J V White; Kazuto Fukunaga; Mike A Laffan; Matthias P Lutolf; Anna M Randi; Jeffrey A Hubbell
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

Review 2.  Leveraging advances in biology to design biomaterials.

Authors:  Max Darnell; David J Mooney
Journal:  Nat Mater       Date:  2017-11-24       Impact factor: 43.841

3.  * Programmed Platelet-Derived Growth Factor-BB and Bone Morphogenetic Protein-2 Delivery from a Hybrid Calcium Phosphate/Alginate Scaffold.

Authors:  Emily A Bayer; Jahnelle Jordan; Abhijit Roy; Riccardo Gottardi; Morgan V Fedorchak; Prashant N Kumta; Steven R Little
Journal:  Tissue Eng Part A       Date:  2017-06-27       Impact factor: 3.845

4.  3D Printed Neural Regeneration Devices.

Authors:  Daeha Joung; Nicolas S Lavoie; Shuang-Zhuang Guo; Sung Hyun Park; Ann M Parr; Michael C McAlpine
Journal:  Adv Funct Mater       Date:  2019-11-08       Impact factor: 18.808

Review 5.  3D Bioprinting for Organ Regeneration.

Authors:  Haitao Cui; Margaret Nowicki; John P Fisher; Lijie Grace Zhang
Journal:  Adv Healthc Mater       Date:  2016-12-20       Impact factor: 9.933

6.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

Review 7.  Local and targeted drug delivery for bone regeneration.

Authors:  Maureen R Newman; Danielle Sw Benoit
Journal:  Curr Opin Biotechnol       Date:  2016-04-08       Impact factor: 9.740

8.  Effects of human urine-derived stem cells on the cementogenic differentiation of indirectly-cocultured periodontal ligament stem cells.

Authors:  Xiao Yang; Xue Xiong; Wenwen Zhou; Gang Feng; Yuanyuan Zhang; Hongwei Dai; Jianping Zhou
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

9.  Preconditioning of surgical pedicle flaps with DNA plasmid expressing hypoxia-inducible factor-1α (HIF-1α) promotes tissue viability.

Authors:  Kai-Hua Chang; Pouria Shoureshi; Frank Lay; Raul Sebastian; Zahra Alikhassy Habibabady; Louis J Born; Guy P Marti; Stephen J Meltzer; John M Abraham; John W Harmon
Journal:  Gene Ther       Date:  2020-10-06       Impact factor: 5.250

10.  Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.

Authors:  Yuchen Wang; Maureen R Newman; Marian Ackun-Farmmer; Michael P Baranello; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.